在合成凝聚剂平台中调节与分子的蛋白质相互作用
Thijs W van Veldhuisen1, Renske M J Dijkstra1, Auke A Koops1
1Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, 5600 MB Eindhoven, The Netherlands.
Journal of the American Chemical Society
|January 28, 2025
概括
研究人员开发了一种合成凝聚剂平台,以发现稳定蛋白质-蛋白质相互作用 (PPI) 的分子. 这种新方法克服了传统测试的局限性,使得可以更好地识别潜在的药物候选物,用于错误监管的PPI引起的疾病.
科学领域:
- 生物化学
- 化学生物学
- 药物发现
背景情况:
- 错误调节的蛋白质与蛋白质相互作用 (PPI) 与许多疾病有关.
- 稳定PPI的分子是有前途的治疗药物.
- 经典测试难以识别和评估弱PPI及其分子合物的调节.
研究的目的:
- 展示一种用于研究PPI和分子合物的新型合成凝聚剂平台.
- 模仿拥挤的细胞环境以更准确地评估分子合物.
- 为了能够有效地选和评估分子.
主要方法:
- 开发了基于粉衍生物的冷凝剂,以创建拥挤的宏分子环境.
- 使用基于亲和性的吸收来招募14-3-3枢纽蛋白,从而达到高局部蛋白度.
- 通过核受体PPARγ对凝聚剂环境 (pH,氧化还原) 的控制和选分子.
主要成果:
- 凝聚剂平台通过封存增强弱PPI,促进分子选.
- 凝聚物中的高局部蛋白质度可以有效识别分子.
- 该系统成功地证明了向PPARγ- 同调剂相互作用的分子合剂.
结论:
- 合成凝聚剂平台为研究PPI和分子提供了一个模仿细胞的环境.
- 这种方法增强了弱的PPI,并允许有效评估小分子稳定.
- 该平台为系统发现新型分子提供了一个有前途的策略.
相关概念视频
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Cooperative Allosteric Transitions
7.8K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.8K
Covalently Linked Protein Regulators
1.6K
1.6K
Protein Complexes with Interchangeable Parts
2.5K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.5K


